MindRank in Phase 3 trial with China’s first AI-assisted new drug, cutting R&D costs by 60%
Hangzhou-based biotech start-up MindRank has progressed to Phase 3 clinical trials for its weight-loss drug, making it China’s first artificial intelligence-assisted Category 1 new drug to reach this stage. MindRank announced last month that it had initiated a Phase 3 clinical trial in China for MDR-001, a small molecule GLP-1 receptor agonists designed with the […]
Try This Once and Notice What Happens After You Eat | Dr. Mandell
Most people focus on what they eat, but very few realize that the order you eat your food can dramatically change how your body responds. In this video, I show you a simple eating sequence that can help flatten blood sugar spikes, reduce insulin overload, improve digestion, and support metabolic health, without changing the foods […]
Fast food goes GLP-1: Shake Shack joins protein craze with new Ozempic-friendly menu
From bunless burgers to cups filled with meat, fast food chains are reshaping their menus as weight-loss drugs and wellness trends change how Americans eat. Shake Shack is one of the latest brands to lean into the GLP-1 era with a new menu designed to make high-protein, lower-carb ordering easier. The burger chain recently launched […]
GLP-1 Agents Showed Broader Risks, Rewards in 2025
(MedPage Today) — In January 2025, we reported about an observational study of nearly 2 million U.S. military veterans that showed a broad spectrum of possible risks and benefits associated with GLP-1 receptor agonists. In this report, we follow…
Pharma generics: Semaglutide patent expiry to open Rs 50bn opportunity; Indian players eye FY27 boost
Semaglutide patent expiries in India, Canada, and Brazil are poised to unlock over Rs 50 billion in revenue for generic drugmakers within 12-15 months. Indian companies like Alkem, Dr Reddy’s, and Sun Pharma are set to benefit, with price drops expected to boost GLP-1 therapy adoption.
Analysts Keep Buy Ratings on Fractyl Health (GUTS)
Fractyl Health, Inc. (NASDAQ:GUTS) is one of the 10 Best New Penny Stocks to Invest In. On December 19, Canaccord Genuity reiterated its Buy rating on Fractyl Health, Inc. (NASDAQ:GUTS) with a price target of $8. This comes after a series of virtual meetings with the company’s leadership, including Co-founder and Chief Executive Officer, Dr. […]
What your butt shape could reveal about your health, according to scientists
An often-overlooked part of the body may reveal important clues about overall health. Researchers from the University of Westminster in the U.K. discovered that the shape of the gluteus maximus muscle in the buttocks changes with age, gender, lifestyle and frailty, as well as certain conditions like osteoporosis and type 2 diabetes. Using advanced MRI […]
GLP-1 Drugs May Reduce Asthma Symptoms in Overweight Teens
Post Content
Prediction: this S&P 500 sector could produce the best returns in 2026
Over the past year, the best-performing S&P 500 sector was communication services, followed by information technology. This might not surprise some, but with us now in 2026, I don’t think either of those two areas will be the best place to invest. Rather, I think it could be another sector that could steal the limelight […]
Obesities, Vol. 6, Pages 1: The Interplay Between Insulin Resistance, Affective Dysregulation, and Binge Eating in Obesity: Toward an Integrated Biopsychosocial Treatment Model
Obesities, Vol. 6, Pages 1: The Interplay Between Insulin Resistance, Affective Dysregulation, and Binge Eating in Obesity: Toward an Integrated Biopsychosocial Treatment Model Obesities doi: 10.3390/obesities6010001 Authors: Luna Carpinelli Carolina Amato Daniela Abate Marinelli Giovanna Stornaiuolo Giulia Savarese Background: Obesity is increasingly recognized as a complex condition characterized by the convergence of metabolic dysregulation and […]